1. Home
  2. ZG vs VTRS Comparison

ZG vs VTRS Comparison

Compare ZG & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ZG

Zillow Group Inc.

HOLD

Current Price

$56.71

Market Cap

16.4B

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$14.36

Market Cap

14.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZG
VTRS
Founded
2004
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.4B
14.8B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
ZG
VTRS
Price
$56.71
$14.36
Analyst Decision
Buy
Hold
Analyst Count
28
6
Target Price
$85.38
$11.83
AVG Volume (30 Days)
699.5K
8.5M
Earning Date
02-10-2026
02-26-2026
Dividend Yield
N/A
3.51%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,483,000,000.00
$14,124,400,000.00
Revenue This Year
$17.67
N/A
Revenue Next Year
$14.41
$1.25
P/E Ratio
N/A
N/A
Revenue Growth
15.17
N/A
52 Week Low
$56.63
$6.85
52 Week High
$90.22
$13.87

Technical Indicators

Market Signals
Indicator
ZG
VTRS
Relative Strength Index (RSI) 26.20 76.62
Support Level $63.50 $12.92
Resistance Level $69.29 $13.41
Average True Range (ATR) 2.47 0.34
MACD -0.90 0.06
Stochastic Oscillator 6.89 92.82

Price Performance

Historical Comparison
ZG
VTRS

About ZG Zillow Group Inc.

Zillow Group Inc is an Internet-based real estate company that offers its customers an on-demand experience for selling, buying, renting, or financing with transparency and ease The group works with real estate agents, brokers, builders, property managers, and landlords to pair technology with top-notch service. The group has brands such as Zillow, Trulia, StreetEasy, Hotpads, Zillow Rentals, Zillow Premier Agent and others.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: